Clinical Trials Directory

Trials / Completed

CompletedNCT01688778

Telemedicine as a Means to Achieving Good Diabetes Control Among Patients With Type 2 Diabetes

The Copenhagen Rehabilitation Trial Part 2: Telemedicine as a Means to Achieve Good Diabetes Control Among Patients With Type 2 Diabetes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
165 (estimated)
Sponsor
Bispebjerg Hospital · Academic / Other
Sex
All
Age
30 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to investigate the effect of telemedicine among the group of type-2-diabetics who, despite rehabilitation, remain poorly regulated. To describe the patients with regards to vulnerability and social resources and to determine wich groups benefit the most from telemedicine.

Detailed description

Type-2-diabetes is a growing healthcare problem. Both because of the increasing amount of patients and because of the complications of diabetes. Non-pharmacological treatment is considered fundamental in the treatment of patients with type-2-diabetes. In the Community of Copenhagen, all patients diagnosed with diabetes receive rehabilitation. The rehabilitation consists of counseling with regards to nutrition, physical activity, smoking cessation and education about diabetes. Some patients however, remain poorly regulated despite rehabilitation as well as pharmacological treatment. A total number of 165 patients will be randomized to intervention group or standard care.

Conditions

Interventions

TypeNameDescription
BEHAVIORALTelemedicineMonthly video consultations with a nurse as add-on to standard treatment. The nurse has access to bloodsugar- bloodpressure and weight measurements uploaded by the participants to a tablet computer directly from the devices. Patients on Insulin measure bloodsugar twice a day (fasting and before their evening meal). Patients not on Insulin measure bloodsugar once a week (fasting and before their evening meal). All participants measure bloodpressure and weight once a week. The intervention lasts 32 weeks.

Timeline

Start date
2012-06-01
Primary completion
2015-04-28
Completion
2015-04-28
First posted
2012-09-20
Last updated
2018-09-19

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01688778. Inclusion in this directory is not an endorsement.